WBP2 (WW domain binding protein 2)

2017-08-01  

Identity

HGNC
LOCATION
17q25.1
LOCUSID
ALIAS
DFNB107,GRAMD6,WBP-2
FUSION GENES

Other Information

Locus ID:

NCBI: 23558
MIM: 606962
HGNC: 12738
Ensembl: ENSG00000132471

Variants:

dbSNP: 23558
ClinVar: 23558
TCGA: ENSG00000132471
COSMIC: WBP2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000132471ENST00000254806Q969T9
ENSG00000132471ENST00000254806A0A024R8L1
ENSG00000132471ENST00000433525Q969T9
ENSG00000132471ENST00000585462A6NG10
ENSG00000132471ENST00000586257K7EIK1
ENSG00000132471ENST00000587374K7EIN1
ENSG00000132471ENST00000588373K7EJ75
ENSG00000132471ENST00000589642K7ESN4
ENSG00000132471ENST00000590221K7EMC9
ENSG00000132471ENST00000591399Q969T9
ENSG00000132471ENST00000591399A0A024R8L1
ENSG00000132471ENST00000591831K7ENL2
ENSG00000132471ENST00000593002K7EIJ0
ENSG00000132471ENST00000626827K7ENL2

Expression (GTEx)

0
50
100
150
200
250
300
350
400
450

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
341970302022WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-κB activation.11
341970302022WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-κB activation.11
334751982021WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.8
336584852021WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1.5
338371782021WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression.5
341170912021WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex.4
334751982021WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.8
336584852021WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1.5
338371782021WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression.5
341170912021WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex.4
323938342020The emerging roles of WBP2 oncogene in human cancers.14
323938342020The emerging roles of WBP2 oncogene in human cancers.14
305935162019Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study.10
305935162019Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study.10
294970312018WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma.34

Citation

Dessen P

WBP2 (WW domain binding protein 2)

Atlas Genet Cytogenet Oncol Haematol. 2017-08-01

Online version: http://atlasgeneticsoncology.org/gene/57045/wbp2-(ww-domain-binding-protein-2)